[Naltrexone--prevention of recurrence in narcotic dependence and in alcoholism].
Poser
W
W
Universitätskliniken für Psychiatrie und Neurologie, Göttingen.
Ehrenreich
H
H
D000437:Alcoholism / Q000534:rehabilitation*; D003692:Delayed-Action Preparations; D005500:Follow-Up Studies; D006556:Heroin Dependence / Q000534:rehabilitation; D006801:Humans; D008691:Methadone / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use; D009271:Naltrexone / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D009292:Narcotic Antagonists / Q000009:adverse effects / Q000627:therapeutic use*; D009293:Opioid-Related Disorders / Q000534:rehabilitation*; D012008:Recurrence; D016896:Treatment Outcome
D003692:Delayed-Action Preparations; D009292:Narcotic Antagonists; D009271:Naltrexone; D008691:Methadone